nach oben

Rheumatology International

Erschienen in:

01.09.2010 | Review

Fibromyalgia and nutrition, what do we know?

verfasst von: Laura-Isabel Arranz, Miguel-Ángel Canela, Magda Rafecas

Erschienen in: Rheumatology International | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Many people suffer from fibromyalgia (FM) without an effective treatment. They do not have a good quality of life and cannot maintain normal daily activity. Among the different hypotheses for its ethiopathophysiology, oxidative stress is one of the possibilities. Non-scientific information addressed to patients regarding the benefits of nutrition is widely available, and they are used to trying non-evidenced strategies. The aim of this paper is to find out what we know right now from scientific studies regarding fibromyalgia disease and nutritional status, diets and food supplements. A systematic search has been performed on Medline with a wide range of terms about these nutritional issues. The search has been made during 2009, for articles published between 1998 and 2008. Target population: people suffering from FM. Vegetarian diets could have some beneficial effects probably due to the increase in antioxidant intake. There is a high prevalence of obesity and overweight in patients, and weight control seems to be an effective tool to improve the symptoms. Some nutritional deficiencies have been described, it is not clear whether they are directly related to this disease or not. About the usefulness of some food supplements we found very little data, and it seems that more studies are needed to prove which ones could be of help. Dietary advice is necessary to these patients to improve their diets and maintain normal weight. It would be interesting to investigate more in the field of nutrition and FM to reveal any possible relationships.

Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160–172CrossRefPubMed

Weir P, Harlan G, Nkoy F et al (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 12:124–128CrossRefPubMed

Maquet D, Croisier JL, Crielaard JM (2000) Fibromyalgia in the year. Rev Med Liege 55(11):991–997PubMed

Lawrence R, Helmick C, Arnett F et al (1998) Estimates of the prevalence of artritis and selected músculoskeletal disorders in the United States. Artritis Rheum 41:778–799CrossRef

Wolfe F, Ross K, Anderson J et al (1995) The prevalence and characteristics of fibromyalgia in the general population. Artritis Rheum 38:19–28CrossRef

White KP, Speedchley M, Harth M et al (1999) The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26(7):1570–1576PubMed

White KP, Harth M (2001) Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep 5(4):320–329CrossRefPubMed

Valverde M, Juan A, Ribas B et al (2000) Prevalencia de la fibromialgia en la población española. Estudio EPISER 2000. Rev Esp Reumatol 27(5):157

Carmona L, Ballina J, Gabriel R et al (2001) EPISER study group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60(11):1040–1045

10.

Mas AJ, Carmona L, Valverde M et al (2008) EPISER study group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population results from a nationwide study in Spain. Clin Exp Rheumatol 26(4):519–526

11.

Gamero F, Gabriel R, Carbonell J et al (2005) Pain in Spanish rheumatology outpatient offices: EPIDOR epidemiological study. Rev Clin Esp 205:157–163CrossRef

12.

Salaffi F, De Angelis R, Gras W et al (2005) Pain prevalence, investigation group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 23(6):819–828

13.

Bannwarth B, Blotman F, Roué-Le Lay K et al (2008) Fibromyalgia síndrome in the general population of France: a prevalence study. Joint Bone Spine 24. [Epub ahead of print]

14.

Felson DT (2008) Comparing the prevalence of rheumatic diseases in China with the rest of the world. Editorial. Arthritis Res Ther 10:106

15.

Eisinger J, Plantamura A, Marie PA et al (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7(3–4):285–288PubMed

16.

Reinhard P, Schweinsberg F, Wernet D et al (1998) Selenium status in fibromyalgia. Toxicol Lett 96–97:177–180CrossRefPubMed

17.

Ozgocmen S, Ozyurt H, Sogut S et al (2006) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia etiologic and therapeutic concerns. Rheumatol Int 26:598–603CrossRefPubMed

18.

Bagis S, Tamer L, Sahin G et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Reumatol Int 25:188–190CrossRef

19.

Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11(3):131–135CrossRefPubMed

20.

Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84–92CrossRefPubMed

21.

Ozgocmen S, Ozyurt H, Sogut S et al (2006) Current concepts in the pathophysilogy of fibromyalgia: the potential role of oxidative stress and nitric oxide. Reumatol Int 26:585–597CrossRef

22.

Pall ML (2001) Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypotheses 57(2):139–145CrossRefPubMed

23.

Hänninen O, Kaartinen K, Rauma AL et al (2000) Antioxidants in vegan diet and rheumatic disorders. Toxicology 155:45–53CrossRefPubMed

24.

Donaldson MS, Speight N, Loomis S (2001) Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med 1:7CrossRefPubMed

25.

Vecchiet J, Cipollone F, Falasca K et al (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335(3):151–154CrossRefPubMed

26.

Kennedy G, Spence VA, McLaren M et al (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 39:584–589CrossRefPubMed

27.

Richards RS, Wang L, Jelinek H (2007) Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res 38:94–98CrossRefPubMed

28.

Zhang Z, Cherryholmes G, Mao A et al (2008) High plasma levels of MCP-1 and Eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med 2333:1171–1180

29.

Wallace DJ, Linker-Israeli M, Hallegua D et al (2001) Cytokines paly an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40:74–749CrossRef

30.

Wallace DJ (2006) Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 12(1):17–22CrossRefPubMed

31.

Chakrabarty S, Zoorob R (2007) Fibromyalgia. Am Fam Physician 15; 76(2):247–254

32.

Carville SF, Arendt-Nielsen S, Bliddal H et al (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536–541CrossRefPubMed

33.

Perrot S, Dickenson AH, Bennett RM (2008) Fibromyalgia: harmonizing science with clinical practice considerations. Pain Practice 8(3):177–189CrossRefPubMed

34.

Abeles M, Solitar BM, Pillinger MH et al (2008) Update on fibromyalgia therapy. Am J Med 121:555–561CrossRefPubMed

35.

Goldenberg DL, Burckhardt C, Crofford L (2004) Management of fibromyalgia síndrome. JAMA 292(19):2388–2395CrossRefPubMed

36.

Nishishinya MB, Rivera J, Alegre C et al (2006) Intervenciones no farmacológicas y tratamientos alternativos en la fibromialgia. Med Clin 12(8):295–299

37.

Kaartinen K, Lami K, Hypen M et al (2000) Vegan diet alleviates fibromyalgia symptoms. Scand J Rheumatol 29(5):308–313CrossRefPubMed

38.

Bennet RM (2002) A raw vegetarian diet for patients with fibromyalgia. Curr Rheumatol Rep 4(4):284

39.

Azad KA, Alam MN, Hag SA et al (2000) Vegetarian diet en the treatment of fibromyalgia. Bangladesh Med Res Counc Bull 26(2):41–47PubMed

40.

Michalsen A, Riegert M, Lüdtke R et al (2005) Mediterranean diet or extended fasting’s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid artritis and fibromyalgia: an observational study. BMC Complement Altern Med 5:22CrossRefPubMed

41.

Smith JD, Terpening CM, Schmidt SOF et al (2001) Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35:702–706CrossRefPubMed

42.

Geenen R, Janssens EL, Jacobs JWG et al (2004) Dietary glutamate will not affect pain in fibromyalgia. J Rheumatol 31:785–787PubMed

43.

Cairns BE, Svensson P (2005) Dietary glutamate and fibromyalgia. J Rheumatol 32(2):392–393; Author reply 393–394

44.

Cymet TC (2003) A practical approach to fibromyalgia. J Natl Med Assoc 95:278–285PubMed

45.

Arnold LM, Hudson JI, Keck PE et al (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67:1219–1225CrossRefPubMed

46.

Javaras KN, Harrison GP, Lalonde JK et al (2008) Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 69:266–273CrossRefPubMed

47.

Bennett RM, Jones J, Turk DC et al (2007) An internet survey of 2, 596 people with fibromyalgia. BMC Musculoskeletal Disorders 8:27CrossRefPubMed

48.

Patucchi E, Fatati G, Puxeddu A et al (2003) Prevalence of fibromyalgia in diabetes mellitus and obesity. Recent Prog Med 94:163–165

49.

Yunus MB, Arslan S, Aldag JC (2002) Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31:27–31CrossRefPubMed

50.

Mengshoel AM, Haugen M (2001) Health status in fibromyalgia–a followup study. J Rheumatol 28:2085–2089PubMed

51.

Shapiro JR, Anderson DA, Noff-Burg S (2005) A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res 59:275–282CrossRefPubMed

52.

Neumann L, Lerner E, Glazer Y et al (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27(12):1543–1547CrossRefPubMed

53.

Shaver JLF, Wilbur J, Robinson P et al (2006) Women’s health issues with Fibromyalgia syndrome. J Women’s Health 9(15):1035–1045

54.

Hooper MM, Stellato TA, Hallowell PT et al (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes 31:114–120CrossRef

55.

Ananda A, Caterson I, Sambrook P et al (2008) The impact of obesity on the musculoskeletal system. Int J Obes 32(2):211–222CrossRef

56.

Lowe JC, Yellin J, Honeyman-Lowe G (2006) Female fibromyalgia patients: lower resting metabolic rates than matched healthy controls. Med Sci Monit 12(7):CR282-9

57.

Loevinger B, Muller D, Alonso C et al (2007) Metabolic syndrome in women with chronic pain. Metab Clin Exp 56:87–93PubMed

58.

Verheesen RH, Schweitzer CM (2008) Iodine deficiency, more than cretinism and goiter. Med Hypotheses 71:645–648CrossRefPubMed

59.

Pamuk GE, Pamuk ON, Set T et al (2008) An increased prevalence of fibromyalgia in iron deficiency anemia and thalassemia minor and associated factors. Clin Rheumatol 27:1103–1108CrossRefPubMed

60.

Swezey RL, Adams J (1999) Fibromyalgia: a risk factor for osteoporosis. J Rheumatol 26(12):2642–2644PubMed

61.

Al-Allaf AW, Mole PA, Paterson CR et al (2003) Bone health in patients with fibromyalgia. Rheumatology 42:1202–1206CrossRefPubMed

62.

Plotnikoff GA, Quigley JM (2003) Prevalence of severe hipovitaminosis D in patients with persistent nonspecific musculoskeletal pain. Mayo Clin Proc 78:1463–1470CrossRefPubMed

63.

Block SR (2004) Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 79(12):1585–1591CrossRefPubMed

64.

Warner AE, Arnspiger SA (2008) Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 14(1):12–16CrossRefPubMed

65.

Armstrong DJ, Meenagh GK, Bickle I (2007) Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 26:551–554CrossRefPubMed

66.

Mouyis M, Ostor AJK, Crisp AJ et al (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology 47:1348–1351CrossRefPubMed

67.

Sendur OF, Tastaba E, Turan Y et al (2008) The relationship between serum trace elements levels and clinical parameters in patients with fibromyalgia. Rheumatol Int 28:1117–1121CrossRefPubMed

68.

Rosborg I, Hyllén E, Lidbeck J et al (2007) Trace element pattern in patients with fibromyalgia. Sci Total Environ 385:20–27CrossRefPubMed

69.

Eisinger J, Plantamura A, Marie PA et al (1994) Selenium and magnesium status in fibromyalgia. Magnes Res 7(3–4)–285–288

70.

Schwarz MJ, Offenbaecher M, Neumeister A et al (2002) Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 11:434–442CrossRefPubMed

71.

Torpy DJ, Papanicolaou DA, Lotsikas AJ et al (2000) Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6. A pilot study in fibromyalgia. Arthritis and Rheumatism 43(4):872–880

72.

Maes M, Verkerk R, Delmeire L et al (2000) Serotoninergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res 97:11–20CrossRefPubMed

73.

Rohr UD, Herold J (2002) Melatonin deficiencies in women. Maturitas 41(1):S85–S104CrossRefPubMed

74.

Caruso I, Puttini PS, Cazzola M et al (1990) Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 18:201–209PubMed

75.

Puttini PS, Caruso I (1992) Primary fibromyalgia syndrome and 5-HTP: a 90-day open study. J Int Med Res 20:182–189

76.

Nicolodi M, Sicuteri F (1996) Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis therapy. Adv Exp Med Biol 398:373–379PubMed

77.

Birdsall TC (1998) 5-Hydroxytriptohan: a clinically-effective serotonine precursor. Altern Med Rev 3(4):271–280PubMed

78.

Merchant RE, Carmack CA, Wise CM (2000) Nutritional supplementation with chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14:167–173CrossRefPubMed

79.

Merchant RE, Andre CA, Wise CM (2001) Nutritional supplementation with chlorella pyrenoidosa for fibromyalgia syndrome: a double-blind, placebo-controlled, crossover study. J Musculoskelet Pain 9(4)

80.

Merchant RE, Andre CA (2001) A review of recent clinical trials of the nutritional supplement chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med 7(3):79–91PubMed

81.

Rossini M, Di Munno O, Valentini G et al (2007) Double-blind, multicenter trial comparing acetyl-l-carnitine with placebo in the treatment of fibomyalgia patients. Clin Exp Rheumatol 25(2):182–188PubMed

82.

Lister RE (2002) An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo Biloba extract in Fibromyalgia Syndrome. J Inter Med Res 30:195–199

83.

Olson GB, Savage S, Olson J (2000) The effects of collagen hydrolysat on symptoms of chronic fibromyalgia and temporomandibular joint pain. Cranio 18(2):135–141PubMed

84.

Bramwell B, Ferguson S, Scarlett N et al (2000) The use of ascorbigen in the treatment of fibromyalgia patients: a preliminary trial. Altern Med Rev 5(5):455–462PubMed

85.

Jacobsen S, Danneskiold-Samsoe B, Andersen RB (1991) Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol 20(4):294–302

86.

Fetrow CW, Avila JR (2001) Efficacy of the dietary supplement S-adenosyl-L-methionine. Ann Pharmacother 35:1414–1425CrossRefPubMed

87.

Dykman KD, Tone C, Ford C et al (1998) The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 33(1):61–71

88.

Werbach MR (2000) Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 5(2):93–108PubMed

Titel: Fibromyalgia and nutrition, what do we know?
verfasst von: Laura-Isabel Arranz
Miguel-Ángel Canela
Magda Rafecas
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 11/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1443-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2010

Ultrasonographic assessment of clinically diagnosed trigger fingers

Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis

Lupus or tuberculosis: which comes first?

Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test

Clinical and radiological features of Takayasu’s arteritis patients in Jordan